Trial · NCT04321031
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Placebo | 34 | |
| Overall Study | STARTED | DGAT2i/PF-06865571 25 mg BID | 35 | |
| Overall Study | STARTED | DGAT2i/PF-06865571 75 mg BID | 48 | |
| Overall Study | STARTED | DGAT2i/PF-06865571 150 mg BID | 42 | |
| Overall Study | STARTED | DGAT2i/PF-06865571 150 mg BID + ACCi/PF-05221304 5 mg BID | 35 | |
| Overall Study | STARTED | DGAT2i/PF-06865571 300 mg BID | 31 | |
| Overall Study | STARTED | DGAT2i/PF-06865571 300 mg BID + ACCi/PF-05221304 10 mg BID | 30 | |
| Overall Study | COMPLETED | Placebo | 32 | |
| Overall Study | COMPLETED | DGAT2i/PF-06865571 25 mg BID | 31 | |
| Overall Study | COMPLETED | DGAT2i/PF-06865571 75 mg BID | 45 | |
| Overall Study | COMPLETED | DGAT2i/PF-06865571 150 mg BID | 35 | |
| Overall Study | COMPLETED | DGAT2i/PF-06865571 150 mg BID + ACCi/PF-05221304 5 mg BID | 32 | |
| Overall Study | COMPLETED | DGAT2i/PF-06865571 300 mg BID | 26 | |
| Overall Study | COMPLETED | DGAT2i/PF-06865571 300 mg BID + ACCi/PF-05221304 10 mg BID | 28 | |
| Overall Study | NOT COMPLETED | Placebo | 2 | |
| Overall Study | NOT COMPLETED | DGAT2i/PF-06865571 25 mg BID | 4 | |
| Overall Study | NOT COMPLETED | DGAT2i/PF-06865571 75 mg BID | 3 | |
| Overall Study | NOT COMPLETED | DGAT2i/PF-06865571 150 mg BID | 7 | |
| Overall Study | NOT COMPLETED | DGAT2i/PF-06865571 150 mg BID + ACCi/PF-05221304 5 mg BID | 3 | |
| Overall Study | NOT COMPLETED | DGAT2i/PF-06865571 300 mg BID | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04321031/flow